By JESSICA CLARK

Updated: 22:03 BST, 2 July 2025

Private equity giant KKR has trumped Advent with a £4.7billion takeover bid for Spectris.

In another blow to the City, the British scientific testing kit maker is the latest firm to leave the London stock market.

It came as research from broker Peel Hunt showed the UK is on course for the biggest year of takeovers since 2021, after £74billion of offers so far this year.

The Spectris board withdrew support for the £4.4billion Advent bid in favour of KKR.

New York buyout group KKR was dubbed the ‘barbarians at the gate’ for its fearsome reputation following a 1989 takeover of RJR Nabisco, which was turned into a book and film.

Spectris chairman Mark Williamson said: ‘KKR’s offer provides attractive and immediate cash value for shareholders and a compelling vision for the future of the group the board believes will be to the benefit of stakeholders.’

Takeover target: British scientific testing kit maker Spectris is the latest firm to leave the London stock market

Takeover target: British scientific testing kit maker Spectris is the latest firm to leave the London stock market

It comes amid a flurry of takeovers on London’s stock market. Last month, KKR lost out when the GP surgery owner Assura accepted a £1.8billion offer from Primary Health Properties.

Microchip designer Alphawave agreed a £1.8billion takeover by US software giant and Nvidia rival Qualcomm. 

And in the last few months, ready meal maker Greencore bought food manufacturer Bakkavor for £1.2billion and Dowlais, the car parts arm of GKN, was snapped up for £1.1billion by American Axle and Manufacturing.

DIY INVESTING PLATFORMS

Easy investing and ready-made portfolios

AJ Bell

Easy investing and ready-made portfolios

AJ Bell

Easy investing and ready-made portfolios

Free fund dealing and investment ideas

Hargreaves Lansdown

Free fund dealing and investment ideas

Hargreaves Lansdown

Free fund dealing and investment ideas

Flat-fee investing from £4.99 per month

interactive investor

Flat-fee investing from £4.99 per month

interactive investor

Flat-fee investing from £4.99 per month

Account and trading fee-free ETF investing

InvestEngine

Account and trading fee-free ETF investing

InvestEngine

Account and trading fee-free ETF investing

Free share dealing and no account fee

Trading 212

Free share dealing and no account fee

Trading 212

Free share dealing and no account fee

Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.

Compare the best investing account for you

:
Private equity giant KKR wins takeover battle for British scientific testing kit maker Spectris



***
Read more at DailyMail.co.uk